University of Pennsylvania at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Pennsylvania brings 40 presentations to ASH 2026 in New Orleans. Its program centres on cell therapy, myeloma and sickle cell disease. It covers armored CAR T cells for CD19-positive lymphoma and long-term blood toxicity after CAR T therapy.
| Organization | ASH 2026 Attendance |
|---|---|
University of Pennsylvania Philadelphia, PA | |
Private research university in Philadelphia, home to the Perelman School of Medicine. | Symposium Fri Dec 11 7:00am–10:00am B-Cell–Directed Therapies in Immune Thrombocytopenia: Real-World Practice Newer B-cell-targeting treatments for immune thrombocytopenia and how to fit them into care to achieve lasting platelet responses. Session Fri Dec 11 2:45pm–3:15pm Symposium Fri Dec 11 3:00pm–6:00pm Evidence at Every Step: Applying the Latest CAR T-Cell Data Across the NHL Care Continuum Getting relapsed lymphoma patients to CAR-T sooner, with earlier referral, bridging therapy, sequencing choices, and management of immune and nerve toxicities. Talk Fri Dec 11 4:30pm–5:20pm Talk Fri Dec 11 4:35pm–5:15pm Talk Fri Dec 11 5:04pm–5:53pm Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About BCMA-Directed Antibody-Drug Conjugates and Bispecific Antibodies in Multiple Myeloma – What Clinicians Want To Know Answers to community oncologists' top questions on B-cell maturation antigen-targeted antibody-drug conjugates and bispecific antibodies in multiple myeloma. Oral Sat Dec 12 9:30am–11:00am Talk Sat Dec 12 2:00pm–3:15pm Flt3 inhibitors in newly diagnosed and relapsed patients Evidence behind current Flt3 inhibitor use in newly diagnosed and relapsed acute myeloid leukemia, and where investigational approaches are heading. Oral Sat Dec 12 2:00pm–3:30pm Session Sat Dec 12 4:00pm–5:35pm JOINT SESSION - New Horizons in RNA Biology in Myeloid Development and Malignancy How RNA regulation, from splicing to RNA-binding proteins, shapes healthy blood formation and myeloid cancers, and how it could point to new treatments. Oral Sat Dec 12 4:00pm–5:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 8:00am–9:00am Oral Sun Dec 13 9:30am–11:00am Talk Sun Dec 13 4:30pm–5:45pm Beyond Remission: Long-Term Hematopoietic Toxicity and Second Malignancies After CAR-T Cell Therapy Persistently low blood counts and second cancers after CAR-T therapy, including their frequency, causes, and how to monitor, prevent, and manage them. Oral Sun Dec 13 4:30pm–6:00pm Oral Sun Dec 13 4:30pm–6:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 10:30am–11:45am Indications and Timing of Splenectomy in Hereditary Hemolytic Anemia When and how to remove the spleen in inherited red cell membrane and enzyme disorders, weighing benefit against lifelong infection and clotting risks. Session Mon Dec 14 12:15pm–1:15pm Oral Mon Dec 14 2:45pm–4:15pm Talk Mon Dec 14 4:30pm–6:00pm Rational Design of FVIII Variants for Gene Therapy: Linking Molecular Insight to Therapeutic Performance Engineering a better version of the clotting protein missing in hemophilia A for gene therapy, balancing stronger bleeding control against clot risk. Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Session Tue Dec 15 11:30am–1:00pm |
Find decision makers at University of Pennsylvania
Tell us what you sell and we’ll find the people at University of Pennsylvania most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction